Literature DB >> 29179253

Mucosal Melanoma: New Insights and Therapeutic Options for a Unique and Aggressive Disease.

Benjamin A Lerner, Latoya A Stewart, David P Horowitz, Richard D Carvajal.   

Abstract

Mucosal melanoma is a rare disease that is distinct from melanomas arising at other sites in the body. While melanocytes are most abundant in the skin, they can be found in smaller numbers in the mucous membranes, as well as in the eye. There are epidemiologic, genetic, and other physiologic differences between melanomas arising from melanocytes at these various sites, and these differences have important implications for both disease prognosis and treatment. Here, we review the features of mucosal melanoma that distinguish it from melanomas arising at other sites, and we highlight recent biological discoveries and emerging treatment options for this aggressive disease.

Entities:  

Mesh:

Year:  2017        PMID: 29179253

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  16 in total

1.  Particulate mediators of the bystander effect linked to suicide and interferon-β transgene expression in melanoma cells.

Authors:  Lucrecia Agnetti; Chiara Fondello; María Florencia Arbe; Gerardo C Glikin; Liliana M E Finocchiaro
Journal:  Gene Ther       Date:  2020-03-03       Impact factor: 5.250

2.  Primary sinonasal malignant melanoma with systemic metastasis in a non-gray horse.

Authors:  Hitoshi Hatai; Takashi Hatazoe; Haruka Seo; Teruaki Tozaki; Shingo Ishikawa; Noriaki Miyoshi; Kazuhiro Misumi; Seiji Hobo
Journal:  J Vet Diagn Invest       Date:  2020-12-08       Impact factor: 1.279

3.  Systemic adjuvant therapy for adult patients at high risk for recurrent cutaneous or mucosal melanoma: an Ontario Health (Cancer Care Ontario) clinical practice guideline.

Authors:  T M Petrella; G G Fletcher; G Knight; E McWhirter; S Rajagopal; X Song; T D Baetz
Journal:  Curr Oncol       Date:  2020-02-01       Impact factor: 3.677

Review 4.  The mutational landscape of mucosal melanoma.

Authors:  Kelsey W Nassar; Aik Choon Tan
Journal:  Semin Cancer Biol       Date:  2019-10-23       Impact factor: 15.707

5.  Metabolic Reprogramming in Metastatic Melanoma with Acquired Resistance to Targeted Therapies: Integrative Metabolomic and Proteomic Analysis.

Authors:  Laura Soumoy; Corentin Schepkens; Mohammad Krayem; Ahmad Najem; Vanessa Tagliatti; Ghanem E Ghanem; Sven Saussez; Jean-Marie Colet; Fabrice Journe
Journal:  Cancers (Basel)       Date:  2020-05-22       Impact factor: 6.639

6.  Prognostic Value of Peripheral Inflammatory Markers in Preoperative Mucosal Melanoma: A Multicenter Retrospective Study.

Authors:  Yixi Wang; Hao Zhang; Yuhan Yang; Tao Zhang; Xuelei Ma
Journal:  Front Oncol       Date:  2019-10-09       Impact factor: 6.244

Review 7.  Overcoming Immune Evasion in Melanoma.

Authors:  Kevinn Eddy; Suzie Chen
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

Review 8.  Hypoxia-dependent drivers of melanoma progression.

Authors:  Simona D'Aguanno; Fabiana Mallone; Donatella Del Bufalo; Antonietta Moramarco; Marco Marenco
Journal:  J Exp Clin Cancer Res       Date:  2021-05-08

9.  Epidemiological profile of mucosal melanoma in Brazil.

Authors:  Daniel Cohen Goldemberg; Andreia Cristina de Melo; Livia Cristina de Melo Pino; Luiz Claudio Santos Thuler
Journal:  Sci Rep       Date:  2020-01-16       Impact factor: 4.379

Review 10.  Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions.

Authors:  Lili Mao; Zhonghui Qi; Li Zhang; Jun Guo; Lu Si
Journal:  Front Immunol       Date:  2021-06-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.